Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An Integrative Drug Repurposing Pipeline: Switching Viral Drugs to Breast Cancer.

Journal of cellular biochemistry - 1 Jun 2017

Karuppasamy Ramanathan, Verma Kanika, Sequeira Velin Marita, Basavanna Lokapriya Nandan, Veerappapillai Shanthi

Abstract excerpt

The growing incidence rate of breast cancer, coupled with cellular chemotherapeutic resistance, has made this disease one of the most prevalent cancers among women worldwide. Despite the recent efforts to understand the underlying cause of the resistance due to mutation, there are no feasible tactics to overcome this bottleneck. This issue could be addressed by the concept of polypharmacology-disguising drugs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Paclitaxel
Share to Hydrophobic and Hydrophilic Interactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Docking Simulation

Share to Anilides

Share to Carbamates

Share to Drug Repositioning

Share to Drug Screening Assays, Antitumor

Share to Tubulin

Source

Identifiers

PMID: 27859674
DOI: 10.1002/jcb.25799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An Integrative Drug Repurposing Pipeline: Switching Viral Drugs to Breast Cancer.PMID 27859674Read ↗

Computationally repurposing drugs for breast cancer subtypes using a network-based approachSemantic proximity Read ↗

Computationally Repurposing Drugs for Breast Cancer Subtypes Using a Network-Based ApproachSemantic proximity Read ↗

Systematic identification of drug-based prognostic biomarkersby integrating multiomics in breast cancerSemantic proximity Read ↗

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read ↗

Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesSemantic proximity Read ↗

Computational Advancements in Cancer Combination Therapy PredictionSemantic proximity Read ↗

NPDI-BcCov: A Network Pharmacology Approach for Simultaneous Inference of Drugs Targeting Breast Cancer and COVID-19Semantic proximity Read ↗

Rational Discovery of Dual-Action Multi-Target Kinase Inhibitor for Precision Anti-Cancer Therapy Using Structural Systems PharmacologySemantic proximity Read ↗

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read ↗

The p53/MDM2/MDMX-targeted therapies—a clinical synopsisSemantic proximity Read ↗

Managing Drug Resistance in Cancer: Role of Cancer Informatics.Semantic proximity Read ↗

Drug repurposing for SARS-CoV-2: a high-throughput molecular docking, molecular dynamics, machine learning, and DFT studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.